Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects
Authors
Keywords
-
Journal
Nature Nanotechnology
Volume 16, Issue 12, Pages 1413-1423
Publisher
Springer Science and Business Media LLC
Online
2021-10-26
DOI
10.1038/s41565-021-00980-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Arsenene: A Potential Therapeutic Agent for Acute Promyelocytic Leukaemia Cells by Acting on Nuclear Proteins
- (2020) Xiuxiu Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
- (2020) Wenjun Wang et al. Nature Nanotechnology
- Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges
- (2020) Nicholas J. Short et al. Cancer Discovery
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cryo-EM structure of the human ferritin–transferrin receptor 1 complex
- (2019) Linda Celeste Montemiglio et al. Nature Communications
- The effect of protein expression on cancer cell capture using the Human Transferrin Receptor (CD71) as an affinity ligand
- (2019) Veronica J. Lyons et al. ANALYTICA CHIMICA ACTA
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma
- (2018) Kelong Fan et al. ACS Nano
- Transferrin and transferrin receptors update
- (2018) Hiroshi Kawabata FREE RADICAL BIOLOGY AND MEDICINE
- Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
- (2018) Haiying Qin et al. Molecular Therapy-Oncolytics
- Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia
- (2017) L Lhermitte et al. LEUKEMIA
- CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
- (2017) Terry J Fry et al. NATURE MEDICINE
- ADDENDUM: T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
- (2016) E. Zah et al. Cancer Immunology Research
- Iron binding to human heavy-chain ferritin
- (2015) Cecilia Pozzi et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Chronic Lymphocytic Leukemia
- (2014) Chadi Nabhan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection
- (2014) M. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles
- (2013) Chenchen Qian et al. BIOMATERIALS
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- cp2k: atomistic simulations of condensed matter systems
- (2013) Jürg Hutter et al. Wiley Interdisciplinary Reviews-Computational Molecular Science
- Advances in the molecular pathobiology of B-lymphoblastic leukemia
- (2012) Yi Zhou et al. HUMAN PATHOLOGY
- Magnetoferritin nanoparticles for targeting and visualizing tumour tissues
- (2012) Kelong Fan et al. Nature Nanotechnology
- Modern Therapy of Acute Lymphoblastic Leukemia
- (2011) Renato Bassan et al. JOURNAL OF CLINICAL ONCOLOGY
- Controlling Assembly of Paired Gold Clusters within Apoferritin Nanoreactor for in Vivo Kidney Targeting and Biomedical Imaging
- (2011) Cuiji Sun et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Arsenic trioxide — An old drug rediscovered
- (2010) Ashkan Emadi et al. BLOOD REVIEWS
- Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
- (2010) Clement Yedjou et al. Journal of Hematology & Oncology
- Binding and uptake of H-ferritin are mediated by human transferrin receptor-1
- (2010) Li Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Arsenic Trioxide Controls the Fate of the PML-RAR Oncoprotein by Directly Binding PML
- (2010) X. W. Zhang et al. SCIENCE
- Insight into the selectivity of arsenic trioxide for acute promyelocytic leukemia cells by characterizing Saccharomyces cerevisiae deletion strains that are sensitive or resistant to the metalloid
- (2007) Pierre J. Dilda et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started